PeriOperative ISchemic Evaluation-3 Trial: A Pilot Study
Status:
Completed
Trial end date:
2016-08-01
Target enrollment:
Participant gender:
Summary
A placebo-controlled, factorial trial to assess the impact of rosuvastatin and tranexamic
acid (TXA) in patients undergoing noncardiac surgery who are at risk of a perioperative
cardiovascular event.
Phase:
Phase 3
Details
Lead Sponsor:
McMaster University Population Health Research Institute
Collaborators:
Hamilton Health Sciences Corporation Population Health Research Institute